Funder: National Institutes of Health

Due Dates: February 16, 2025 (New) | March 16, 2025 (Renewal/Resubmission/Revision) | June 16, 2025 (New) | July 16, 2025 (Renewal/Resubmission/Revision) | October 16, 2025 (New) | November 16, 2025 (Renewal/Resubmission/Revision) | February 16, 2026 (New) | March 16, 2026 (Renewal/Resubmission/Revision)

Funding Amounts: Up to $275,000 in direct costs over 2 years; no more than $200,000 in any single year; project period max 2 years.

Summary: Supports translational and clinical research to advance precision medicine, drug safety, and novel therapeutics for pregnant and lactating persons, fetuses, neonates, and children.

Key Information: Clinical trials are optional; foreign organizations are eligible; Data Management and Sharing Plan required.